newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference

ZURICH, SWITZERLAND / ACCESSWIRE / March 25, 2022 - NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW))) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients wit